<SEC-DOCUMENT>0001842952-25-000037.txt : 20250409
<SEC-HEADER>0001842952-25-000037.hdr.sgml : 20250409
<ACCEPTANCE-DATETIME>20250409073314
ACCESSION NUMBER:		0001842952-25-000037
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250409
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250409
DATE AS OF CHANGE:		20250409

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Context Therapeutics Inc.
		CENTRAL INDEX KEY:			0001842952
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				863738787
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40654
		FILM NUMBER:		25823835

	BUSINESS ADDRESS:	
		STREET 1:		2001 MARKET STREET
		STREET 2:		SUITE 3915 UNIT #15
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103
		BUSINESS PHONE:		267-225-7416

	MAIL ADDRESS:	
		STREET 1:		2001 MARKET STREET
		STREET 2:		SUITE 3915 UNIT #15
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Context Therapeutics LLC
		DATE OF NAME CHANGE:	20210128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cntx-20250409.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:36673d5f-14c2-41de-820e-e717e31f8de8,g:30551f68-c904-40b5-8c6e-5d63944b1a44,d:47a93923d63749bea9c79cc0be831c1a-->
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cntx-20250409</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-24">0001842952</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-25">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cntx-20250409.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001842952</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-09</xbrli:startDate><xbrli:endDate>2025-04-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i47a93923d63749bea9c79cc0be831c1a_1"></div><div style="min-height:18pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.955%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.833%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.833%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pursuant to Section 13 OR 15(d)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">of The Securities Exchange Act of 1934</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">April 9, 2025</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.833%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:21.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Context Therapeutics Inc.</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.833%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.821%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-40654</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">86-3738787</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%">(State of other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">2001 Market Street,</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 3915</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine3" id="f-9">Unit #15</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Philadelphia</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">Pennsylvania</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">19103</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%">(Address of principal executive offices including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">(267)</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">225-7416</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:26.833%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric> &#160;&#160;&#160;&#160;&#160;&#160; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric> &#160;&#160;&#160;&#160;&#160;&#160; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric> &#160;&#160;&#160;&#160;&#160;&#160; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.686%"><tr><td style="width:1.0%"/><td style="width:31.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.874%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.338%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.876%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Title of each class</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Trading <br/>Symbol</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Name of exchange<br/>on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-19">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-20">CNTX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-21">The Nasdaq Stock Market</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:3pt;padding-right:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">$0.001 par value per share</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'MS PGothic',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-22">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-indent:-0.01pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric> </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.955%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i47a93923d63749bea9c79cc0be831c1a_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 7.01. Regulation FD Disclosure.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">On April 9, 2025, Context Therapeutics Inc. (the "Company") issued a press release announcing that the first patient has been dosed in the Company&#8217;s Phase 1 clinical trial evaluating CT-95. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information in this Item 7.01, and Exhibit 99.1 attached hereto, are being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filing.</span></div><div id="i47a93923d63749bea9c79cc0be831c1a_10"></div><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 8.01. Other Events.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">On April 9, 2025, the Company announced that the first patient has been dosed in the Company&#8217;s Phase 1 clinical trial evaluating CT-95. The Company anticipates sharing initial data for the CT-95 Phase 1 trial in mid-2026.</span></div><div><span><br/></span></div><div id="i47a93923d63749bea9c79cc0be831c1a_13"></div><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(d) Exhibits</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.944%"><tr><td style="width:1.0%"/><td style="width:13.375%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.760%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%;text-decoration:underline" href="a20250409-ctx95firstpatien.htm">Press Release issued by Context Therapeutics Inc., dated April 9, 2025</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (embedded within the inline XBRL document)</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i47a93923d63749bea9c79cc0be831c1a_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:12pt;padding-right:-7.47pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:12pt;text-indent:22pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.944%"><tr><td style="width:1.0%"/><td style="width:53.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Dated: April 9, 2025</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Context Therapeutics Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">By: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">/s/ Martin A. Lehr</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Name: Martin A. Lehr</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Title: Chief Executive Officer</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a20250409-ctx95firstpatien.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i65fd5a56142547de8efdbb16756e250a_1"></div><div style="min-height:81.36pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 99.1</font></div><div style="text-align:center"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:59px;margin-bottom:5pt;vertical-align:text-bottom;width:178px"></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Context Therapeutics Doses First Patient in Phase 1 Clinical Trial of CT-95</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">CT-95 is a mesothelin x CD3 T cell engaging bispecific antibody </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">CT-95 is Context&#8217;s second T cell engaging bispecific antibody to enter the clinic in 2025</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PHILADELPHIA, PA, April 9, 2025</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> -- Context Therapeutics Inc. (&#8220;Context&#8221; or &#8220;Company&#8221;) (Nasdaq&#58; CNTX), a biopharmaceutical company advancing T cell engagers for solid tumors, today announced that the first patient has been dosed in the Phase 1 clinical trial of CT-95, a mesothelin (&#8220;MSLN&#8221;) x CD3 T cell engaging (&#8220;TCE&#8221;) bispecific antibody designed to target mesothelin-expressing cancers.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Company anticipates sharing initial data for the CT-95 Phase 1 trial in mid-2026.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This milestone marks Context&#8217;s second active clinical trial, following the dosing of the first patient in the CTIM-76 trial earlier this year. CTIM-76 is a Claudin 6 (&#8220;CLDN6&#8221;) x CD3 TCE bispecific antibody currently being evaluated in CLDN6-positive tumors, including ovarian, endometrial, and testicular cancers.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">MSLN is a membrane protein overexpressed in an estimated 30% of all cancers with limited expression in normal tissues. CT-95 is being developed as a therapy for advanced cancers associated with MSLN expression, including pancreatic, ovarian, mesothelioma, and other solid tumors.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Dosing of the first patient in our CT-95 Phase 1 clinical trial represents another step forward in our mission to develop next generation precision immunotherapies for solid tumors,&#8221; said Martin Lehr, CEO of Context. &#8220;With both CT-95 and CTIM-76 now dosed in initial patients, we are advancing our clinical pipeline and expanding our leadership in T cell engaging bispecific antibody therapies.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Phase 1 clinical trial of CT-95 (</font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">NCT06756035</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) is an open-label, dose escalation and expansion study to evaluate the safety and efficacy of CT-95 in subjects with MSLN-expressing advanced solid tumors, including ovarian, pancreatic, lung, and mesothelioma cancers. The dose escalation and dose expansion portions of the trial are expected to evaluate safety, tolerability, and pharmacokinetics, as well as anti-tumor activity by overall response rate, duration of response, and disease control rate. The dose escalation portion of the study is expected to enroll up to 30 patients.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About CT-95</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CT-95 is a MSLN x CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing MSLN. MSLN is a membrane protein overexpressed in approximately 30% of cancers. One challenge in developing MSLN-targeted therapies has been the presence of MSLN fragments, also referred to as shed MSLN, found in both blood and the tumor microenvironment that can serve as a decoy or sink for MSLN-targeting antibodies.  CT-95 is a fully humanized bispecific T cell engager that has a moderate affinity but high avidity for membrane-bound MSLN, that is intended to minimize the impact of the shed MSLN.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:81.36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Context Therapeutics&#174;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Context Therapeutics Inc. (Nasdaq&#58; CNTX)&#160;is a biopharmaceutical company advancing T cell engaging (&#8220;TCE&#8221;) bispecific antibodies for solid tumors. Context is building an innovative portfolio of TCE bispecific therapeutics, including CTIM-76, a Claudin 6 x CD3 TCE, CT-95, a Mesothelin x CD3 TCE, and CT-202, a Nectin-4 x CD3 TCE. Context is headquartered in Philadelphia. For more information, please visit&#160;</font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.contexttherapeutics.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;or follow the Company on&#160;</font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">X</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (formerly&#160;Twitter)&#160;and&#160;</font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">LinkedIn</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-looking Statements</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This press release contains &#8220;forward-looking statements&#8221; that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, included in this press release regarding strategy, future operations, prospects, plans and objectives of management, including words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;look forward,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; and similar expressions (as well as other words or expressions referencing future events, conditions, or circumstances) are forward-looking statements. These include, without limitation, statements regarding (i) our expectation to share initial data in mid-2026 for CT-95, (ii) our expectation to enroll up to 30 patients in the dose escalation portion of the Phase 1 clinical trial evaluating CT-95, (iii) the potential benefits, characteristics, safety and side effect profile of our product candidates, (iv) the likelihood data will support future development, and (v) the likelihood of obtaining regulatory approval for our product candidates. Forward-looking statements in this release involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements, and we therefore cannot assure you that our plans, intentions, expectations, or strategies will be attained or achieved. Other factors that may cause actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in our filings with the&#160;U.S. Securities and Exchange Commission, including the section titled &#8220;Risk Factors&#8221; contained therein. Except as otherwise required by law, we disclaim any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events, or circumstances or otherwise.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Investor Relations Contact&#58;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Jennifer Minai-Azary</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Context Therapeutics Inc.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IR&#64;contexttherapeutics.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cntx-20250409.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:36673d5f-14c2-41de-820e-e717e31f8de8,g:30551f68-c904-40b5-8c6e-5d63944b1a44-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cntx="http://www.contexttherapeutics.com/20250409" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.contexttherapeutics.com/20250409">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cntx-20250409_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cntx-20250409_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.contexttherapeutics.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cntx-20250409_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:36673d5f-14c2-41de-820e-e717e31f8de8,g:30551f68-c904-40b5-8c6e-5d63944b1a44-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentPeriodEndDate_2080798b-ebf3-41ae-8c6e-57616aae14bc_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_d66c8189-0431-441e-822a-a3f24799438c_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_dd920d38-e7f5-4b69-b5c6-a2663d1a0985_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2fa95153-fa7b-473b-b7a1-b1f111b7df7e_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b45e4285-21c5-4187-b4b7-559645625d14_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2d55f577-4542-489e-b627-3647fc73f8cf_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_25e78208-396e-4953-8646-c0ba515be3c3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_4e7e7e00-c564-4de8-a985-7ded830aa785_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8aa54126-1359-4bd5-87d0-575a042cd245_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_6b75378b-302f-44ae-b928-17195128a803_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d89a8161-bf70-4ec1-a3a0-dbf8e15ff101_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7dfd7684-d628-48d2-a6c0-af22076e78f7_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_681a1c8c-2e4c-416e-8901-bc3ac157cbb0_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e2a5d2cf-14a0-420e-a169-6c3d591aa337_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_e07127b9-3568-4c75-8667-c2045a553106_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_650081a9-d77e-4eec-9a33-7369c3eee620_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_36d6ca5c-ebc6-4c67-9afd-47709667a813_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a30bdd85-effb-4503-bcb4-8e0e0c44afe7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_261bac4a-2e01-4f50-a2e5-035be5479cb1_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a658a269-df47-49fd-93f0-067ef4ca3170_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_0a8fec20-971b-493c-b3d0-00fe12db75f6_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_50e0aefa-01f1-425d-b5c8-1d3435f4a315_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_35f4cfc4-0551-428c-a8ad-2563dd6ce268_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine3_18a5051e-56cb-42f5-9255-b1896b3f6f40_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine3_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine3" xlink:to="lab_dei_EntityAddressAddressLine3" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_eb35a82d-f8b9-4129-bda5-fb80fe747872_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cntx-20250409_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:36673d5f-14c2-41de-820e-e717e31f8de8,g:30551f68-c904-40b5-8c6e-5d63944b1a44-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.contexttherapeutics.com/role/Cover" xlink:type="simple" xlink:href="cntx-20250409.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.contexttherapeutics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_52429bd6-b0fd-406d-855c-20c6761e7aa3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_DocumentType_52429bd6-b0fd-406d-855c-20c6761e7aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_904d8829-703e-4822-88ac-6f5607edae68" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_DocumentPeriodEndDate_904d8829-703e-4822-88ac-6f5607edae68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4209c956-40fc-42e3-9113-c580c503d597" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityRegistrantName_4209c956-40fc-42e3-9113-c580c503d597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_922dd6b8-87dd-4403-87ee-eef44470aa77" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityIncorporationStateCountryCode_922dd6b8-87dd-4403-87ee-eef44470aa77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d8e2febf-aa69-40b1-8165-744d6f8c296e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityFileNumber_d8e2febf-aa69-40b1-8165-744d6f8c296e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_52a767f9-a210-417f-9278-01becfecdfa7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityTaxIdentificationNumber_52a767f9-a210-417f-9278-01becfecdfa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_45a967ee-bb9e-4343-9021-9d1cf6a0c9d4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityAddressAddressLine1_45a967ee-bb9e-4343-9021-9d1cf6a0c9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_dad14c36-e496-45a1-86d5-a615b63a3e7f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityAddressAddressLine2_dad14c36-e496-45a1-86d5-a615b63a3e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3_79102a22-7dc6-4d4d-a8c3-f397c6900f2e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityAddressAddressLine3_79102a22-7dc6-4d4d-a8c3-f397c6900f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f988e8af-efbc-4640-bedd-92aee5b8c8d8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityAddressCityOrTown_f988e8af-efbc-4640-bedd-92aee5b8c8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_832eebe3-9cdc-4eb2-af2a-63e2bae10c8a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityAddressStateOrProvince_832eebe3-9cdc-4eb2-af2a-63e2bae10c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_53709a24-1227-4e54-a387-2942823bb066" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityAddressPostalZipCode_53709a24-1227-4e54-a387-2942823bb066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b23b9b7f-e094-4e39-8bad-14cfee53e39f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_CityAreaCode_b23b9b7f-e094-4e39-8bad-14cfee53e39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_048d3900-5ca7-4d1a-a7ec-563c633bdbc6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_LocalPhoneNumber_048d3900-5ca7-4d1a-a7ec-563c633bdbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_1cdc2ad0-225e-4112-8683-8954bf5996bb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_WrittenCommunications_1cdc2ad0-225e-4112-8683-8954bf5996bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_c65c268e-763d-4987-b8c7-de41a2dc2c68" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_SolicitingMaterial_c65c268e-763d-4987-b8c7-de41a2dc2c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_3787f1ac-9830-4930-86e0-2840e31d158d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_PreCommencementTenderOffer_3787f1ac-9830-4930-86e0-2840e31d158d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_81aa6ca5-2025-457b-864f-ee6c1ddd81fc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_81aa6ca5-2025-457b-864f-ee6c1ddd81fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8b3db515-590a-413d-a9d0-586c65158ed3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_Security12bTitle_8b3db515-590a-413d-a9d0-586c65158ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2ded8730-04f8-4e0f-9bee-156124b94169" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_TradingSymbol_2ded8730-04f8-4e0f-9bee-156124b94169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7f84bef5-3052-4db7-b1df-e0811028e6c8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_SecurityExchangeName_7f84bef5-3052-4db7-b1df-e0811028e6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_10823d5f-e614-4b19-82f1-af65dba7f6b1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityEmergingGrowthCompany_10823d5f-e614-4b19-82f1-af65dba7f6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_29666f5e-64e5-40ea-a734-6b61f9a5f0e9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityExTransitionPeriod_29666f5e-64e5-40ea-a734-6b61f9a5f0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7c23c950-153d-4b24-b5ee-5a73d5b3bf31" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_EntityCentralIndexKey_7c23c950-153d-4b24-b5ee-5a73d5b3bf31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_806a8014-aa0e-40f1-9f0e-914cbe4d791d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_64b972b0-375b-430d-9a39-a1f76b7ed559" xlink:to="loc_dei_AmendmentFlag_806a8014-aa0e-40f1-9f0e-914cbe4d791d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
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MN;JCJ733W4ZM<?L0         " 0X1 DY!?9_EH6!QAV-&H0TJW_2I#0^Q
M        ((@ 0Y#QK%!W,:X8- 3H8\9!2+>\:B7$%_\!AB ,0P
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M         (! =ZRS(L 7U#-E=>__'15V=&F 'J;+(E4OO6X8A
MX@KPY72_&15VM## ]C,(81 "         !A4@"^GPP]">CVM"M!!Q$'(D@ =
M, @!         $PMP)?331F$1+PJI'A0NN0AZ1-ZB?Z,&08A         -!F
M ;Z<;L0@I-?5F@ ]1.N$00@         (*X 7TXWZ4O_2,_#6*CNH\ @!
M       06C?NLR_^[\MKS^*N^!90X[HQGHFQ2-W#N 8-0HI]:*&Z+P
M  ! S;JQKG((_:7_./$P9(EZ^R=JP/ZS-NJ>         * QNF.=^9[5?7X!
M6_SOQCQ;JE_W=(K7UHWW[(O0@Y!"5S,,6:S>[JGXZQH-O@\Q" $       "
M?O2&!BOG\$5L,1 YQC.BWH:I=&/_JO\@=3_3J;FWA>KMG8F_O@4!]A4&(0
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MES"WM^F6 Z,4717/(IFOWCZDUTUWA5'Q[QQ1;]],NMK;[RV+="X!
M4*-N>9]^];!CIBQ4=S19[PO=A;VAR%R_U%[>^W?PY6P+=<LKC);W,I>K1-9,
M^.>;\#R0",\@6L'Q!@       +10-_;5($7"W!YK)MWRMD>S;<NJWA?@(^K7
MBWBZY95!C1L,SB;($&0\IZG[         %"C;MQG@TQ.^%]Q]P8ARZ=(,?@H
MKOS@UE>846\_631+1M6O<U"!AB"-'28!        F*/>%_7J+R7[R3'%E\#J
MO@ ,+L#Y8W)6J#L!        4),&#4**+%?W!6 PW?YN&:?(B+H;
M #7HCG56!OA"DD$(D"D_;A<$.'=,E8/4W0        "H07>LLR; %Y(,0H ,
M]88@JP.<.Z8*M\<"        VJ#;K%MC+5+W!: _W;A7@DS,B+HG
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M=0< JM$[GZ@''E-EC;H;         $+=\C99JQB" !B&'],C 88>4V61NAL
M        8MWR >I+Z_IU=C%\46\S@.IU8SU[J,@2=2<       ! %KICG5=X
MEGE63_H2;D7O_W\\!ZI?ZTS\]2U(_$7F<L^(>CL!I-$MKS"+,@RYM,NS00
M     (#A]+[TFSS\F"TK/6-1OZ#K;=.E";Z47*3>-@#I]0:J#$$       "
MINJ.=0[T'-.=^@J00;(ZZD"D6]XJ:]$4Z6>[%D_QSW$K+*!%NNFO+F,( @
M     %2M-QQ8D>!+N[ #D<GZW)Y1]>L$H-?5W":+(0@        P%[TO]%(,
M028/1!:HMW4FQ9"CC_ E)("UNNENM3=5EG#^ 0       .:@.[?G@ R38_@R
M#T NNN75=$L3GS<7J;<3        :"3!$&0\*QB& ,A)-\US0U9UN1T?
M    ,#?"(0C#$ !9ZET=<M <KA I!A[+)V4QYT@       !@C@(,0<:S6-T%
M *30&XH45XDLZ0TZN/45        4(= 0Y#QS%=W @"I^;ENQ#-:##UZ5WM,
MO/ICH?KU 0       -GH_3I9/?S@%ED          *!:O5NU1+H:A&$(
M      "H1G'[E0!#C^DRJNX'           T6'>LLS+ P&.Z<$4(
M  "8FV[Y@%[UL&/:J/L!           -U1WKC*@''7UDKR+JK@
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M_$/[QIXQSVV3/LR/YW/JUP@  *#6>\_T7L_MT[QG.DK]&A%(-^ZS0M:HNP$
M  " NOB']7F>EWNNG^;#_'@^KWZM    *KWW3*_TW##+>R9N)XI["WI5"+?%
M @   - *_D%]=\^*63[,CV>)^O4"   H^/N@)WDNZ_,]$X,0W%LWWK-"EJL[
M 0   (#4_ /Z#IY3^OPP/YXOJ%\W  ! G?S]SXCGM '?,_%<-=Q7=ZQS:8 !
MR-I;8GFV5/<!     *GX!_--/(</^&&>00@  &@5?]^SF>>C<WS/]%GUZT=
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M\U7UM@,  /3+W[OL[#E7\)[IB^IM!P    "@D?Q#]6:>(P0?YL=SNKH#  "
MV?A[EBT\_^/YB^@]$X,0       &X1^FYWGV\]PL'((P" $  *'Y>Y5U/*_W
M_$[\GNE8=1<      #2&?Y!^HN=2\8=Y!B$  " T?Y^RN^?R .^7BGQ)W0<
M     .'Y!^C[>[[HN2? A_GQ\(P0   0BK\_V=YS?(#W20Q"      #HAW]P
M7L_S[YX_!/@0SR $  "$Y.]+UO<<ZKDMP'NDR3E.W0\      "'YA^:G>*X,
M\.%]NBQ5=P0  .#O2?;Q7!7@O=%T.5[=$0      H?B'Y1T]IP?XT,X@!
MA.7O11[M^4: ]T2SA2M"       H^(?D+3R+/7\.\(&]GYRF[@P  +2/OP?9
MVO,ISUT!W@_UDR^K.P,     0,H_'*_K>9/GMP$^J#,( 0  (5GY[+2W>%8'
M>!\T2$Y0=P<     @(Q_,'Z6YV<!/J#/):>J^P,  .W@[SN>:[&?G<8@!
M  " B:R\I_6W WPP9Q "  #"\O<;.WN6!WC?,TQ.5/<(     $!MK'GWM&80
M @  :N?O,[;U'.7Y2X#W/,/F)'6?F$)WK#/?\PK/V*0\S[-7+_/5KQ,
MFL*:>T_KF?(5=:\  " O_OYB?<_;/;<$>*_#("1'O0'(,D^WSQSC&5&_;@
M  "(S)I]3VL&(0  H!;^WN(%GJL#O,>I.B>KNVV]8I#1N\*CN-IC]0!#$ 8B
M     # +_^"[48 /WZERBKI?  "0!W]?L7F ]S:\9\I-=ZRSI6?%' <?#$0
M    H \,0@   &;'( 25Z]T":V7%0Y")*6ZO-:K>3@    !0RWP0PFT>  !
M)3(?A' [T;IUQSH+AK@%UJ!9R4/5 0   +09@Q   (#993X(.57=;ZMTQSH+
M:QJ 3$QQ^ZTMU=L.      J9#T).4O<+  #RP" $E1 -0?[OV2'J[0<
M!08A    L_/W%9L%>&_#(*3)>K?#4@U!QK-0W0,     U(U!"   P.P8A& H
MW?+!Z'4]$V2F%*]A1-T'     -2)00@  ,#L&(1@SHIG<P09@O"\$     "M
MQ" $  !@=@Q",&?=L<ZB ,./R5FF[@4     ZI+Y(.1$=;\  " /#$(P)P&O
M!IF8@]3]     $ =&(0   #,SM]7;!K@O0V#D*8)>C7(>!:I^P$   " .C (
M 0  F!V#$ PL^-4@11:K.P(   " .C ( 0  F!V#$ PL^-4@19;W7N>(MBD
M    2(M!"   P.PR'X1\1=UOEHI!0X!AQXR#$,]"SZBZ*P    !(*?-!R GJ
M?@$ 0!X8A&!@P6^+562%9R6#$     "Y8Q "   P.W]?L4F ]S8,0IHDP*"C
MWXRJNP(   " E!B$    S(Y!" 868,#!( 0     .@Q"    ^L$@! ,+,.!@
M$ (     G>P'(5]6]PL  /+ ( 0#ZXYUU@08<C ( 0   -!Z#$(   !FQR $
M ^N.=98'&'(P" $   #0>ID/0HY3]PL  /+@[RLV#O#>)E5.4?>;I>Y89U&
M(0>#$     "ME_D@A"M"  ! )8PK0C"H[EAG08 AQTPIKE@9\6RI[@H
M4LI\$'*\NE\  )"'S <A7!&22C?V<T(6J_L!    @#ID/@@Y4=TO  #( X,0
MS$EWK+,DP,!CNBQ2]P,     =<A\$'*RNE\  ) '!B&8D^Y89WZ @0>#$
M  "MEOD@A/M= P" 2C (P9SUGL6A'GI,E07J;@    "@#ID/0DY3]PL  /+
M( 1SUBT?2*X>>DS.$G4O     %"7S <A7U7W"P  \L @!$/ICG46!QA^C&>I
MN@\     J%/F@Y"OJ?L%  !Y8!""H77'.I<&&((4KV%+=1<     4*?,!R%?
M5_<+  #RP" $0^O=(FL-0Q      J%?F@Y"SU/T" ( \, A!);ICG?FB80A#
M$     "ME?D@Y&QUOP  ( ^9#T).5O?;*H)A"$,0     *V6^2#D6^I^ 0!
M'AB$H%(U#D.6, 0!    T':9#T+.4?<+  #RP" $E2L&%-VT#U!?I-Y&
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M>UG/&-0>D+AC!B%YA4$(D ,_F!_K^5R DTIN*>Y)_C3U^J*Y?/_9S?,IS^H
M^W,.6>D9\^R@7EO,C3$(J:+#XI9Z[_#\*D /T7*%,1"9E3$(R2U)OP1J$^_R
M99;OK053YUO&CU8JYYUN;^5M(=7K&R&O5*]'--[)^P*LB_2\4T/'#$+R"H,0
MH*FL?+#RLZU\TZD^F>2>RSS[>394KSOB\_UD"RMOM;8BP+Z;<XISWPO4ZXW!
M6#ZWQJI]$&+EN67,\[L VQ\]%WKVJGN-FL(8A.06!B%#\/[6][S><VV M<PA
M%UOY'*)UU&N;"^]RGP#K&B%K/ ]0KT<4WL43/7<'6!=5BN=K)K^UN3$(R2T,
M0H"F\0-W8\\;K/S5H_HDTK84?VS?;SQ@'5.P\B'%1UCY0$GUOMJF7.,YV+.Y
M>A_ ['R=OA=@GZDB5]78V=:>#WAN#;#=3<M9GAWK6JNF, 8AN85!R!QX;QMY
MWNRY/L :YICB_=D;/1NKUSH'WN.2 &L:(:>HUR("[V$#SU4!UD.96IY39 Q"
M<@N#$*!)K/RR[[<!3AZD?"@MM^=!<5S^C>?H /MDVU,\2^0SGD>I]PE,S_*Y
M-58M@Q#_[[R[MV^KM[?I.:R.]6H*[^.T &M"JLL;U/M4TWAGKS-N+UA7BIY?
MHU[SIK/RMIC7!5C/"'F.>CW4O(./!E@'98ZHL>NO!=A>4ET8A #1^8&ZKN?5
MQAN?B"E^^7^(9P/U?H+Z^;H_W/.% /LAN6^*0>5#U?L([LO7Y=P ^T<527IK
M+/_W_S_/SP)L9T[YB6>7E.O6%,8@)+<P".F3=_44S^4!UJR-*?ZF<<O"(7A_
M>UB[;X4TGF*XMH5Z/51\V__><T^ =5"EN&UY;=^_&(.0W,(@!(C,#](7>GX>
MX&1!9DYQ6>J>ZOT%]?"UWL;*!Z#_.<"^1Z;/GSP?MQKN'8O^63Z#D"17A%CY
MB\^/!=B^G//!%&O7),8@)+<P")F%E5?O<GN3&#G#LY-ZGV@J*V_3K%[#"/F<
M>BT4K'R?V.;G&1572==Z_C &(;F%00@0D1^<>WLN"G"2((/E!./Y(=FR\OD\
M[S'NT]^TW.%YMWK_0<D8A,S43?&W_Y<!MJT-N<1:?-68,0C)+:]7[U.1>3\'
M&K<8C)C_]FRFWC^:QCM;S\H'TJO7+T):]T-$W^8C _2N3.V#?V,0DEL8A "1
M^$&YN>>D "<',O?<YGFS>E]"M8H_F)X; ^Q?9.XIKMQZFGI?:CMC$#)5)\67
M&I\(L$UMRQK/,ZM:QR8Q!B&YA4'(%+R7'3T7!E@?,GUN\(RJ]Y6FL?+VO SW
M=KQCI6=C]7K4I3A6 G2NS!FBWAF$Y!4&(4 4?D#NZ;D^P(F!5).O&K]R:CQ?
MPQ'+YXM;4N8KGAW4^U9;970\_:*B/A[L^5& [6EKBGML?]"S;A7KV12^O4L#
M=$^JR^O4^U0T5CX,G2^*FY'B/%Q<'=*:+[2KX'WM'V#M(N2CZK6H@Y4_F&WS
MC_)^X]E*U/T9 ;:?5!<&(8":'XCK>SYB[7[@5:ZYQG@P:R/YNLWSO,G**WS4
M^Q&I/K=[7J3>S]K(&(1,[.*IGM\%V!92?LA=KXI]O F,04AN81#2XUUL:ESQ
MU-2L]#Q)O0\UB?=U=H!U4Z?X#F57]5JDYMMX;("NE7FJL'L&(7F%00B@Y ?A
M8SP_"7 R(.E2_!IM?_6^AOX95X&T*4L\]U/O<VWB??\@P+I7D3D/0OR?7<?S
M7L_= ;:#_#7%!]WUJ]S?HS(&(;F%04AG[7Z]JV=5@/4@P^5P];[4%-[5=IZ;
M ZR9.I=;QC]F\&U[7H".E?F8N'\&(7F%00B@X@?@09X[ YP(2#TYSK.)>K_#
MS'R-%AJW4FA;KO0\0;WOM87E,V3\WSEN_R:>;P1X_63JG%GU/A^1,0C)+:]5
M[U-JWL%^QONWG++<LXUZOVH"[VGO .L5(>]1KT4*OEU;>7X?H%]5+O-L(%X#
M!B%YA4$(H. 'WRD!3@"D_A2_5GF0>O_#U'QM/A=@'R&ZO%&]#[:!M7@0XO_,
MUIX+ KQV,G/.2;'O1V(,0G)+:P<AONT;6OEC(_4:D.ISG>=QZGVL";RG_PFP
M7NK<Y=E1O195LW;_O2Z&VSL%6 ,&(7F%00A0)S_HMO"<%^#@)[I<ZWF8>E_$
M7Q7K8=RBCI0YV7A89U*6SZVQKAIPNQ]2_#,!7C?I+Y]/=0Q$8.W^8B7'M'(0
MXMM]?\\E ?HGZ7*'YX7J?2TZ[V@CSQ4!UDN='WKFJ=>C*KXM_Q:@4V5>KUZ#
M@C$(R2T,0H"Z6/DE"&]02)%?>QZOWB>Q]KA\KN</ ?8)$B<_LPQ_41:%Y3,(
MN7J ;7Z4YZ8 KYD,EFR?N^#;]M4 _9+JTKIGT?DV/]1S38#N23UYGV7T!7<*
MWL\N5EX5H5XK==ZL7HLJ^'9L[[DE0)^JG*%>@W'^6KX>H ]271B$ '7P@VUG
MXTL0<N\4;VSV4.^;;>;]'Q%@/R Q<[OG!>I]-$>6SR#DFCZW]^\\:P*\7C)X
M_FR9_ITV!B&YI56#$"NOY+TA0.^DWGS9LZYZ_XO,^SDDP#JI4UQ%]&#U6@S+
MMV%9@"Y5^8UG*_4:C#,&(;F%00B0FA]H>QF_."=3IWBC]A3U/MHVWOF#/!<&
M6'\2/^]4[Z^YL18-0OQ_\V3CX;U-3W$%Y_WK.#;J9 Q"<DMK!B&^K8\V?ES6
MYIRBW@<C\W[F><X/L$[J?%.]%L/PU[]_@ Z5>:IZ#28R!B&YA4$(D)(?9"\*
M<*"3^'F6>E]M"RM_17AM@#4GS<D7C%\@5L;R>4[6REFV<W<KKRQ2OTXR?);5
M=7S4Q1B$Y);7J/>I.OAV[NI9':!OHDUQO_X-U?MC5-[-#M;N6RJ-YQ7JM9@+
M*V_[=UN _E3YJ'H-)C,&(;DEQB"D.];9TC/69YY7_._5KQF8C1]@+_;<'>!
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M/-^S\IRN?EU-R;/5^WY$WLOVGM\'6!]E7I6XXZ4!ME&51OU]FHHQ",DM#$*
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MTLI!R)K*-AI9\P-D:8"#-$**/^+OL KO65L5?TV/9)WN^*1Z'5+S;=S0<VV
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M;B1M7J/>UW)F#$+:JSO6F>]9WD=&U*\5^? #\U\"G!Q2Y_KBY*KN.AKOY(8
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M[+X=EP;H,E4^J^ZW22SO9T8]4-VODN4]G,[B7#PL[^%9 =8B94[WC)$YY:@
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MW?EW];'79M[_5IX; ^P'$5(\FW)/]9J@&L8@)([N6.>T ,..F;)(W1&:PP_
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M0+N^UDA-_M+ O*3,R[5K;)74YDX-U]IO[?Q>R0LE#Y?<4G)Y[?/$><F<W-K
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MD%H\V\!\]"%^"]7S:<_W/%S80NW[!FI(NIV^;HGU9@.UUTHK=E20<5Y <MA
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M^0(         @!XHM\(ZF*D),LEAFB$          " YA2;()!LT0P
M    0#+CX=)^I28(3X8          (!TQL.E@7(3A&8(          !HWCB\
M%V3#0!.$9@@          &C6>+@T,M#\V)R#VG4!           M-QXN+1MH
M>FR7@79]          ! B_DG+PPT/&B$          " 9HWMO""=1@@
M     &C6>+BT9J#9,2LKVC4"           M9:#1417?J.&EZ0
MH)ZQ[9>DGR?:M0(          "TSMO]^D.DL:]<+          "T2)L:(=JU
M @          +4,C!           =!:-$           T%DM:H2L:]<*
M      "T3(L:(:O:M0(          "W3HD;(0+M6          "@9<;#I67)
M40.-CEDYJETG          #04N/AT@[)NH&&QW89:=<(          "TW'BX
M=-Q TV.KK&C7!@          M)SAIT(&VK4!           M9[01LJI=%P
M        T %^"RH#C8_I')'LT*X+          #H"$/-D.,T00
M0.,,-$-\$^1T[3H          (".&@^7]M,$ 0          G34>+JUF;H+X
M=X(L:Y\W     +11,1B<+EF;D17M,0(  'W^=X**WQGXHCKZ)6,S9)UW@@
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M2"-D77N,  !T&3^+ 0    ! :]$( 0  5?A9#       6HM&"   J,+/8@
M    T%HT0@  0!5^%@,     @-:B$0(  *KPLQ@      +06C1   %"%G\4
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M0NH<L\FL-SW^J?,PVP@IFGL'51-1;884^DV025:T:H M*&V'M54VQKQ$'0
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MISQ^Y!B7(ZZQSFZO&?FY.-(>)WJF_!9WS@7,@V.>#@$Z96QG2ZS-Z?6B! #
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M:M?"&^M]L]\?T\33,*AG;'>;N;'5:TK&M6L<GMZ8]PF1H^6_/\F*]CD!
M?1#Q1,@?:X\1  !@2^7BOV8S9$6[!IYB$V2Z&;*L78=%1)ZG?]IF;1RV!5O6
M'O,BQG:?!IFD%4])C,]MC,2<TTA[O    $!?T0@!  "M-@[;0>7>)LLW7TQ\
M8]W0@K:Y[8SJF/.<#UBY#NH:VWX:I'774_DYM%>R?WS>)SXF\>\U&FB/$P
M .@K&B$  *#URF9 [+>R%XV9EQJ7YYW[G2"S,M*N295RP7I8YN X/.&QMN!Y
M^W]_M_:YQ1K;:9Y5Q<1]!@   *#](AHAO",$  "TPSA\&[LW"_UCF]_J-_V$
M1-D 277N:VU8O!^')Q>TKY.8^&VGEK7K!0   *#]:(0  (!.&8=ON_N%WB:?
M$#EJ;8%_;/=;_1L6FP'C\!Z5'$_/F']Y_-AF VV[6JYKUPL   ! ^]$( 0
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MUF8[8^-/SVC7!P        "@9#Q<.JZ]2!V1K-L:M:@18F:1WW@C9+]V?0
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M00          5<;#I4,&FB"J"]IR_+T&&AQ1M=*L4QWCM%ME^?^V6N,,
M     - RBHT ]2;(1$N:(2KO4)E7@F:(OU[V:I\7         *"%?$-BG&=+
MHTG\UD;+VN<]3<:SRT"S8U96M&LT#QGWCG'8,FN2(Y'GN^[/V?\[VN<
M     .B <L$ZQU999K<V,M#LF!433\\L:CR[X>:;'_N[<JX          (/&
M89NHXPD6\OT"^"[M\YO%0+-CNQS1K@T          )TQ#EME-?5TB-\*:47[
MG&*,X[=MRAG?E#+Y! T          *TW'BXMC\/[,]9K+-Z/RG]G67O\=8S#
M]F"6FB%F7B@/         $#GE4^*["^;(INWSSI>_N_KVN-<A*%F"$T0
M      #0/ /-$)H@           @'<5F"$T0          "0GD(SQ!]K6?N\
M 0        ! CXS#>U%2-T$.^<:+]KD"         ( >&@^7!I*CB;;"6M$^
M/P          T'/E5EG[&VR(K/(4"           ,*=LBNPJM[2*;7P<+9L?
M*S1           ! *Y1-$=_<&$G6I[):_F^[> DZ        @*W\/R@JAEN[
/&C*]     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 09, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  09,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Context Therapeutics Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-3738787<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2001 Market Street,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 3915<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Unit #15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Philadelphia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(267)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">225-7416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNTX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001842952<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( "8\B5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( "8\B5J>^-<@[P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DE%+PS 0Q[^*Y+V]IE7!T.5EPR<%P8'B6TAN
M6UC3A.2DW;>WC5N'Z ?P,7?__.YW<*T.0ON(+]$'C&0QW8RNZY/08<4.1$$
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M]7I"/L%SY+.L[45<$28SG_S*]#/,AW =7/4*X?2]RF6]'R==;E6M ^.2BUQ
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M> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( "8\B5J7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ )CR)6JK$(A8S 0
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M6N=6RKV'5[+E&''\GN4/4$L#!!0    ( "8\B5HD'INBK0   /@!   :
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=
M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\
MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X
M\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].
MM.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  F/(E:99!YDAD!  #/ P
M$P   %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=
M< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'
M3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-
MF<!B63R-PLQJ2AFC-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*
M1D.QD8E>I6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXP
MC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,
M:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    (
M "8\B5I&QTU(E0   ,T    0              "  0    !D;V-0<F]P<R]A
M<' N>&UL4$L! A0#%     @ )CR)6I[XUR#O    *P(  !$
M ( !PP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ )CR)6IE<G",0
M!@  G"<  !,              ( !X0$  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    "  F/(E:X7TBPX $  !'$@  &               @($B"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ )CR)6I^@&_"Q
M @  X@P   T              ( !V P  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    "  F/(E:EXJ[',     3 @  "P              @ &T#P  7W)E;',O
M+G)E;'-02P$"% ,4    "  F/(E:JL0B%C,!   B @  #P
M@ &=$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ )CR)6B0>FZ*M
M^ $  !H              ( !_1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ )CR)6F60>9(9 0  SP,  !,              ( !
MXA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  +!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cntx-20250409.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.contexttherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cntx-20250409.htm">cntx-20250409.htm</File>
    <File>cntx-20250409.xsd</File>
    <File>cntx-20250409_lab.xml</File>
    <File>cntx-20250409_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cntx-20250409.htm": {
   "nsprefix": "cntx",
   "nsuri": "http://www.contexttherapeutics.com/20250409",
   "dts": {
    "inline": {
     "local": [
      "cntx-20250409.htm"
     ]
    },
    "schema": {
     "local": [
      "cntx-20250409.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cntx-20250409_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cntx-20250409_pre.xml"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 26,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 25
   },
   "report": {
    "R1": {
     "role": "http://www.contexttherapeutics.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cntx-20250409.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cntx-20250409.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Three",
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.contexttherapeutics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001842952-25-000037-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001842952-25-000037-xbrl.zip
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MSY71#O: @L+$5 \FX24CS0IOHF?#G\B1'/ 2E60+Z7*F9"'I>0,2NJ172PU
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M 9Y3;L+*VZ7Q+&Q'++0YW&3OUX!4Z%=UK6C$7^-E&*_V(VI;*V?][%G"9*"
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M-QKO+]UZ6\[IZ[ !.0B@&CX0PZV^-?ZAG.N?HBPEI<X[67+9O_R+F^6/'2<
M :;L#:1!-4:2?Z"O <+LYXCCATKU]M?'CXZ?G]_3/^_IJ.]I^'W:I_[W>/\-
M4$L#!!0    ( "8\B5H8KS<A4@\   !B   1    8VYT>"TR,#(U,#0P.2YH
M=&WM'&USVCCZ^_X*';W;)C,Q^(TW)V$G2^@>LVV2 3K;N2\WPA9!6V-[93G
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M NS80UO^X-/; DG5Y[P ^N8,^(1YVH#ZJ/D9U'*A\>'B8[>U!+"T2*%@ R;
MA;!XA6!0L9U8J0^@1)2B.Q+$<5Z(^2CR49KJV5 HC.=E4)S$'DA(P;L'DL&,
MPT2H7TIMG(QLA3N2G3]GBK'Y+^[A[P%G@BB<V$J[;K9_7V3XP\F-_-'BZA&P
M)_3R7Z"L0EZ"RVP@/1KX,-2JAV,S-+TUK^8C^>\<2&F![IQ),ZZ4YA2R!&J;
MZBYRAW_+8_X7N7<_)]/W$0^T(4.W[ABU2)Z.N2>'CJ'K_RHLO(?8:-3GMX'C
M GN8@.$XHJ J?8&R3/].EU\&0L4MP.F'4H8CQS !SJKU).W[+)_3#P50J;FA
M[],H9D[^QVENH:FWT]2DTT4(90  H5!RE_H9$ 4O'<YHK->+]7(9R93 3.GE
M@#,.%($#I>7G]5JQKJ\>THN&>EY2ZXE\,..N%<F"F@.$(+/."^ A%VG-L(<W
MB1<FR(MWH*ZG$?4PBCLZ,6"-'$!)$;Z"V>LDE8\#_% XN#(N/@!% P<QXO[4
M>7\A./7?G\00A" Z"CY(AV/^-W.,"C!5_1RG!%5AMI) KCXFZLSGJW:O=4FZ
MO8M>J[NH%@>#8[?5_-QI]]JM+KFXNB2M+\U_7US]UB+-ZT^?VMUN^_IJ+>(;
M:O(N:#$VHN4/&@]!.608G)#+8K,(R5G9KC\7__U:HEDIUBSK "T11$#BT.?>
MDPQQC[JRF=Y_N.Y\(IOG%7F)D&99:?8 ,:2F_;Z<.OQ0MU=7M]?U0^!1.ZVK
M'NFT;JX[O;T[_LV0O$E$G% H>F5(NLS%&HL8%KGN$*-\Y!V_':\?#D@/2G6@
M(1%<<DC16Q-W"!DZ(Q>N)#!LU"W[[="#J3!BW6%1*"0YRG\S"LDPBR5A=]BK
M$&J8><?.$]S8C<JP6VG>O5@F>?!$&\$20YRF>72J30&TQH)9U51H7$2"^Z1^
MHMH?/SS@ 7K 14Y47DZK3:-8WDBOM^T4=-@MC[$))*]@)%<^"]QK5@>#U0L:
ML03D&Y-VX!9WK8@[X$Y](]8<M2847!5R "U=S"@G-"9QQ%PLR3W" \)E3,"Y
M@>&+9[OH'W:VO\1V[^5\S32VY;5E%DV4T".\?JVE[$TT8)VX<XF:T01ENBR?
MAPQ->;FY ^CQ$60=5VQ,.N&(!D]U!4;Y"5X2_%XH(!-03?*NA.#=#)- BFDS
M]!8C._;XL2LG623".USG/J3;D'8PGXZI8&N=J/3^+QG\@?L,7NZ#&6?,*F/G
MU-!LO5*V=\LMGPV6K'O&J]U4#KMBI?D$5O;HI)TUF%VEKXM\K4 ]7=&LJE6K
MUJJ/QW+%WK=A]I5OIT=*+X^4\6+X#R4D-N1/J&9BCZ>%&3SE\X9^_!)6*</H
MU8AOAJ,1CW&_EJ#!D50SOCLRV\5.L5LDK5'DAU,0\J(YD*NPN$CRJW0Y-LM9
MMS7^"\\3+(ZS_S[">D9N^-5" W=AR2<JOC))NE(P)D\>>H MRMQU$,T<8JW0
MZ"8<S,VJ&TOUZ\D.(%DYI'JA\3G@DKQ;AK/OQM"+RK4)?UZ+7CB>Y12&7FC<
M#+E//>9'0TYWQF;E**_%#60Q7.V5;YCD& 8@Q((@GOIW-%A&Z*GXW(0 T/\/
MC]*4*P-F%AI&W="M RQ*-W!7:5F:$8CA)Q+ :QY1G[ )<Z'FOL-8!9X+W".,
M^ DZ8?(WCX!M'EM?F[X1W49UOA",+HC4 I:8E>KQ,Q3G8PB!Z&88!@]R2@,R
M<-,L:U7;J!R@QE0WTY?[ELW/[Z  K9[&1#*?14@O"13!)W/: M4&/61UN0HE
MN8@B'\(S!. #$,-F6UM''\ ?0G*1MI.$<H_PDZ;&# (8D+0_#N4T.E#BTSCO
M)_]H*AUF4^EEU-Y>O7TU9.Y7=?R11A!%P?-C8=(/)Z3/_'",^H.#J&6DIOU.
M!MQ':^88""0+/- K&8)JC1)?TH"%2>Q/20P9;CR8JIG9A+ /4J5Y?8,#<XW/
M!-8!G0VF^=@ ="<<XSR,[!Q+A=C90EOWR<'-X\$?@DO@&98_29"5 ?%R1M,/
M0[]/@0$2Q#"+&>5"X^=W]:IMGRY%I)_?&17]]/%_208<\)N'3J*YG<%. M9L
MF^5,'G)QHPWWUXZ,*FE^Z!#3THOPXC8.Y#!%T@6S=8&^X/83Z#T"WE0>E6?*
MXQXR&66@EX5AV!22RSEY+.QVSJ1A@R=3;[Y]@=P(AO:!)R/5$0QT,>)Z,,#L
M:3/!5)\I&,! <^=0^*;%&+:GF4?]X\W$E+[[W0FJ'<<)$T\05VVMN#:1UI-E
M9C'-/G(WDUGV[I8RV_LN4*56V7H7R"C6JH_OMVS^W+)JN]D$.EBD*B^T,[7I
M5D"VA(;O.Y8J[/-'(LU9U;/7JJ-4V[.'UPS2(RSND+A0;L0KVOF/LVB6.;]2
MLW\'7!!45;WJD'AW.NJ'_A;M[;=/_U5VNH%E3E7Q 7+_\9"#5J2I/Q/,6VZ
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M,%YYVH6L'Q7;[@P:):-Q@ 6O6F23R30KQB5.<SK">5H GHT2P#!-IY"EY:R
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ME[NUF,^SUFV;ZESH6H9&M#2LOBE]H/=W^M)_EO:3O+(38KG_EZ9 4T8 ,58
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MW/T<2=97AJ.->B<UN&[>'N=F/1930*W$>:,*QKO8?J^8,/ )O# L\?S26C\
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M,#(U,#0P.5]L86(N>&UL4$L! A0#%     @ )CR)6K+Y9#4[!P  /S<  !4
M             ( !S"@  &-N='@M,C R-3 T,#E?<')E+GAM;%!+!08
.!0 % % !   Z,      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>cntx-20250409_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cntx-20250409.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001842952</identifier>
        </entity>
        <period>
            <startDate>2025-04-09</startDate>
            <endDate>2025-04-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-24">0001842952</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-25">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-04-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Context Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-40654</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">86-3738787</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">2001 Market Street,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 3915</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="c-1" id="f-9">Unit #15</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Philadelphia</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">19103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">(267)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">225-7416</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-19">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-20">CNTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-21">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-23">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
